Filter
1005
Text search:
priority
medicines
Featured
Recommendations
124
New Publications
271
Language
Document type
No document type
489
Studies & Reports
187
Guidelines
147
Strategic & Response Plan
76
Manuals
61
Fact sheets
15
Situation Updates
13
Training Material
10
Resource Platforms
5
Brochures
1
Infographics
1
Countries / Regions
Global
45
India
38
Kenya
37
Ethiopia
24
South Africa
24
Sierra Leone
22
Uganda
22
Ghana
20
Malawi
18
Western and Central Europe
18
Liberia
17
Nepal
17
Syria
17
Nigeria
15
Africa
15
Zambia
14
Tanzania
14
Rwanda
14
Bangladesh
13
Myanmar / Burma
13
Latin America and the Carribbean
13
Ukraine
12
Eastern Europe
11
Namibia
9
Asia
9
Congo, Democratic Republic of
8
Philippines
8
South–East Asia Region
8
Zimbabwe
7
South Sudan
7
Yemen
7
Middle East and North Africa
7
Senegal
6
Botswana
6
Sudan
5
Guinea
4
Pakistan
4
Cambodia
4
Mozambique
4
Madagascar
4
Lesotho
4
Venezuela
4
Haiti
3
Somalia
3
Afghanistan
3
Lebanon
3
Indonesia
3
Brazil
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Bhutan
3
Cameroon
2
Thailand
2
Benin
2
Hungary
2
Sri Lanka
2
East and Southern Africa
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Russia
2
Moldova
2
United Kingdom
2
Burkina Faso
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Iraq
1
Jordan
1
Turkey
1
Egypt
1
Chad
1
China
1
Papua New Guinea
1
Central African Republic
1
North Macedonia
1
Serbia
1
Burundi
1
Colombia
1
Bolivia
1
Fiji
1
Albania
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Romania
1
Lithuania
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
394
Clinical Guidelines
103
Public Health
57
Women & Child Health
51
Key Resources
47
Pharmacy & Technologies
14
Capacity Building
11
Toolboxes
HIV
93
COVID-19
79
AMR
73
TB
70
Mental Health
55
Pharmacy
41
Conflict
33
Caregiver
29
Disability
26
Ebola & Marburg
22
NTDs
22
Planetary Health
21
Rapid Response
18
NCDs
18
Global Health Education
14
Natural Hazards
12
Health Financing Toolbox
9
Refugee
8
Malaria
7
Zika
5
2.0 Rapid Response
5
Cholera
4
Polio
3
Specific Hazards
3
Typhoon
1
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards
...
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov
...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation
...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products
...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat th
...
Women and girls are paying the price of the war in Yemen – Humanitarian actors must increase the priority given to women and girls’ needs, with specific attention to GBV prevention and response, and reproductive health services
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully co
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
This operational guidance on MHPSS provides a practical orientation and tools for UNHCR country operations. It covers specific points of good practice to consider when developing MHPSS programming and offers advice on priority issues and practical d
...
This document sets out the preparedness and response plan of the Nigerian Primary Health Care System for COVID-19 Acute Respiratory Disease. It outlines the planning scenarios, key areas of work and priority activities required for the Primary Healt
...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca
...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines
...
